The Effect of Oral Antibiotics on the Development of Community Acquired Clostridium Difficile Colitis in Medicare Beneficiaries by Psoinos, Charles M. et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
UMass Center for Clinical and Translational 
Science Research Retreat 
2016 UMass Center for Clinical and 
Translational Science Research Retreat 
May 20th, 12:30 PM 
The Effect of Oral Antibiotics on the Development of Community 
Acquired Clostridium Difficile Colitis in Medicare Beneficiaries 
Charles M. Psoinos 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/cts_retreat 
 Part of the Bacterial Infections and Mycoses Commons, Community Health and Preventive Medicine 
Commons, and the Health Services Administration Commons 
Psoinos CM, Collins CE, Ayturk MD, Flahive J, Anderson FA, Santry H. (2016). The Effect of Oral Antibiotics 
on the Development of Community Acquired Clostridium Difficile Colitis in Medicare Beneficiaries. UMass 
Center for Clinical and Translational Science Research Retreat. Retrieved from 
https://escholarship.umassmed.edu/cts_retreat/2016/posters/68 
Creative Commons License 
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in UMass Center for 
Clinical and Translational Science Research Retreat by an authorized administrator of eScholarship@UMMS. For 
more information, please contact Lisa.Palmer@umassmed.edu. 
The Effect of Oral Antibiotic’s on the Development of Community Acquired 
Clostridium Difficile Colitis in Medicare Beneficiaries 
 
Charles M Psoinos, MD1; Courtney E Collins, MD1; M Didem Ayturk, MS1; Julie M Flahive, MS1; 
Frederick A Anderson Jr, PhD1; Heena P Santry, MD, MS, FACS1. 
 
1University of Massachusetts Medical School, Department of Surgery 
 
Clostridium difficile infection (CDI) is increasingly prevalent among community dwelling 
Americans. Older Americans are particularly vulnerable to community-acquired Clostridium 
difficile (CACD), in part to increasing use of antibiotics.  We studied the association between 
outpatient antibiotics and CACD among Medicare beneficiaries.  
 
Case-control study utilizing a 5% sample of Medicare beneficiaries (2009-2011).  Patients with 
CACD severe enough to warrant hospitalization were identified by a primary diagnosis code for 
CDI and no exposure to a healthcare environment within 90-days of admission. 1,514 CACD 
cases were matched to ten controls each on birth year and sex. Potential controls with exposure 
to healthcare environment were excluded. Outpatient oral antibiotic exposure was classified into 
three groups: ≤30 days, 31-60 days, or 61-90 days prior to case subject’s index admission.  
Metronidazole and Vancomycin were excluded because they are used to treat CDI. 
Multivariable models were utilized to determine the independent effect of antibiotics on the 
development of CACD while controlling for several patient associated characteristics.  
 
Cases of CACD had more outpatient antibiotic exposure in each time period examined: ≤30 
days = 40.0% vs 8.4%;  31-60 = 10.7% vs 5.0%; and 61-90 = 5.5% vs 4.4% (all p-values <0.05).  
Subjects exposed to antibiotics ≤30 days prior to admission had a markedly higher risk of being 
admitted with CACD compared with those not exposed (OR 8.09, 95% CI 7.13, 9.19).  Similarly, 
subjects taking antibiotics 31-60 days and 61-90 days prior to admission had increased risk of 
CDI admission (OR 3.65, 95% CI 3.02, 4.41) and (OR 2.06, 95% CI 1.61, 2.63) respectively. 
 
Recent exposure to outpatient oral antibiotics increases the risk of CACD among community 
dwelling elderly with the risk persisting as long as 90 days after exposure. Inappropriate 
antibiotic usage must be minimized and older Americans who require outpatient antibiotic 
treatment may warrant close observation for signs of CDI.  
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